News

Veterans Exploring Treatment Solutions (VETS) Takes Center Stage at Psychedelic Science 2025

Veterans Exploring Treatment Solutions (VETS) brought its mission to the forefront at Psychedelic Science 2025, spotlighting the urgent need for access, equity, and innovation in veteran mental health. From policy advocacy to powerful storytelling, VETS delivered a bold message: healing is a right—and veterans deserve the freedom to pursue it.

Advocate reacts to Texas governor signing psychedelic research bill into law

Texas has taken a historic step toward advancing psychedelic science and veteran mental health. With the signing of SB 2308, the state will invest $50 million into ibogaine research—opening the door for FDA-approved studies on a treatment veterans have long sought abroad. As VETS continues advocating for clinical access to promising therapies, this milestone positions Texas at the forefront of evidence-based innovation for PTSD, TBI, and addiction.

How the Legacy of the “Bonus Army” Inspired a Modern Protest Movement of Military Veterans

Nearly a century after the original Bonus Army marched on Washington, veterans are once again mobilizing—this time to defend federal jobs, safeguard VA services, and demand dignity. On June 6, the “Bonus Army of 2025” returns to the Capitol, continuing a legacy of veteran-led advocacy. Among them are voices from VETS, helping elevate the call for respect, accountability, and access to the care veterans have earned.

NC lawmakers call for new look at psychedelic drugs for mental health therapy

Bipartisan momentum is building in North Carolina as lawmakers propose a new task force to explore the clinical use of psychedelic-assisted therapies for mental health. Backed by veterans, advocates, and legislators across the aisle, Senate Bill 568 signals a growing recognition of the urgent need for innovative solutions to the mental health crisis.

Psychedelic State(s) of America Puts A Spotlight On Texas

In the debut of Lucid News' “Psychedelic State(s) of America” series, Texas takes center stage as lawmakers and advocates unite behind HB 3717—pushing forward $50 million in state-backed ibogaine research. With powerful voices like VETS co-founders Amber and Marcus Capone influencing legislative momentum, the Lone Star State is emerging as a surprising leader in psychedelic policy reform for veterans and beyond.